Orchestra BioMed Holdings (OBIO) Shares Outstanding (Diluted) (2021 - 2026)

Orchestra BioMed Holdings (OBIO) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 52.24 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 680.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 66.36 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Orchestra BioMed Holdings 235.83 Mn 141.43 Mn 78,000.00 62.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 62.72 Mn
Dec 31, 2025 47.75 Mn
Sep 30, 2025 52.19 Mn
Jun 30, 2025 38.39 Mn
Mar 31, 2025 38.24 Mn
Dec 31, 2024 36.82 Mn
Sep 30, 2024 37.62 Mn
Jun 30, 2024 35.80 Mn
Mar 31, 2024 35.78 Mn
Dec 31, 2023 33.23 Mn
Sep 30, 2023 35.24 Mn
Jun 30, 2023 34.61 Mn
Mar 31, 2023 27.64 Mn
Dec 31, 2022 16.43 Mn
Sep 30, 2022 13.72 Mn
Jun 30, 2022 20.45 Mn
Mar 31, 2022 9.23 Mn
Dec 31, 2021 20.45 Mn
Sep 30, 2021 20.45 Mn
Jun 30, 2021 20.45 Mn